New 52 Week High Today

Regeneron Pharmaceuticals Inc RGO-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR

Last | 8:13 AM CET

693.20

+4.00 (+0.58%)

52 week range

630.00 - 693.20

Open693.20
Day High693.20
Day Low693.20
Prev Close663.00
52 Week High693.20
52 Week High Date02/01/23
52 Week Low630.00
52 Week Low Date01/09/23

Key Stats

Market Cap80,819.9M
Shares Out108.8M
10 Day Average Volume25.2
Dividend-
Dividend Yield-
Beta-
YTD % Change3.62

KEY STATS

Open693.20
Day High693.20
Day Low693.20
Prev Close663.00
52 Week High693.20
52 Week High Date02/01/23
52 Week Low630.00
52 Week Low Date01/09/23
Market Cap80,819.9M
Shares Out108.8M
10 Day Average Volume25.2
Dividend-
Dividend Yield-
Beta-
YTD % Change3.62

RATIOS/PROFITABILITY

EPS (TTM)48.38
P/E (TTM)14.33
Fwd P/E (NTM)-
EBITDA (TTM)-
ROE (TTM)-
Revenue (TTM)-
Gross Margin (TTM)-
Net Margin (TTM)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Regeneron Pharmaceuticals Inc

Jim Cramer's top 10 things to watch in the market MondayJanuary 30, 2023CNBC.com
Monday's top analyst calls: Tesla, Apple, Netflix, Amazon, UPS, Meta, Shopify January 30, 2023CNBC.com
Cowen says buy Regeneron, success of drugs could help pharmaceutical stockJanuary 30, 2023CNBC.com
These stocks usually top Wall Street earnings estimates and rallyJanuary 29, 2023CNBC.com
Cramer’s week ahead: Fed decision on Wednesday could let the bulls ‘party on’January 27, 2023CNBC.com

Content From Our Affiliates

Regeneron Announces Investor Conference Presentations20 Hours AgoTipRanks
Regeneron upgraded at Cowen with Eylea ‘secure’ and pipeline ‘delivering’January 30, 2023TipRanks
Regeneron upgraded to Outperform from Market Perform at CowenJanuary 30, 2023TipRanks
Regeneron, Sanofi announce EC expansion of Dupixent marketing authorizationJanuary 30, 2023TipRanks
Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Eosinophilic EsophagitisJanuary 30, 2023TipRanks

Profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA...

P. Roy Vagelos M.D.

Chairman of the Board

Leonard Schleifer M.D., Ph.D.

President, Chief Executive Officer, Founder, Director

George Yancopoulos M.D., Ph.D.

President, Chief Scientific Officer, Director

Robert Landry

Chief Financial Officer, Executive Vice President - Finance

Daniel Van Plew

Executive Vice President, General Manager - Industrial Operations and Product Supply

Address

777 Old Saw Mill River Road

Tarrytown, NY

10591

United States

https://www.regeneron.com/